Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. [electronic resource]
Producer: 20190812Description: 2114-2119 p. digitalISSN:- 1462-0332
- Adult
- Aged
- Dermatomyositis -- blood
- Drug Therapy, Combination
- Female
- Ferritins -- blood
- Glucocorticoids -- administration & dosage
- Humans
- Interferon-Induced Helicase, IFIH1 -- blood
- Lung -- pathology
- Lung Diseases, Interstitial -- drug therapy
- Male
- Middle Aged
- Piperidines -- therapeutic use
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Pyrroles -- therapeutic use
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.